Bitran, J. D., Goldman, M. (1985) A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen. American Journal of Clinical Oncology, 8: 61–64.
Decker, D. A., Drelichman, A., Jacobs, J., Hoschner, J., Kinzie, J., Loh, J., Wever, A., Al-Sarraf, M. (1983) Adjuvant chemotherapy with cisdiamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer, 51: 1353–1355.
Feld, R., Evans, W. K., Coy, P., Hodson, I., MacDonald, A. S., Osoba, D., Payne, D., Shelley, W., Pater, J. L. (1987) Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. Journal of Clinical Oncology, 5: 1401–1409.
Goldie, J. H., Coldman, A. J. (1979) A mathematical model for relating the drug sensitivity of tumours to the spontaneous mutation rate. Cancer Treatment Reports, 63: 1727–1733.
Goldie, J. H., Coldman, A. J., Gudauskas, G. A. (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treatment Reports, 66: 439–449.
Goodman, G. E., Crowley, J. J., Blasko, J. C., Livingston, R. B., Beck, T. M., Demattia, M. D., Bukowski, R. M. (1990) Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. Journal of Clinical Oncology, 8: 39–47.
Hong, W. K., Schaefer, S., Issell, B., Cummings, C., Luede, D., Bromer, R., Fofonoff, S., D'Aoust, J., Shapshay, S., Welch, J., Levin, E., Vincent, M., Vaughan, C., Strong, S. (1983) A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer, 52: 206–210.
Johnson, J. T., Mayernick, D. G., Myers, E. N., Nolan, T. A., Schramm, V. L., Sigler, B. S., Wagner, R. L. (1987) Cisplatin-5-fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck. Head and Neck Surgery, 9: 336–340.
Kartner, N., Ling, V. (1989) Multidrug resistance in cancer. Scientific American March, 26–33.
Miller, A. B., Hoogstraten, B., Staquet, M., Winkler, A. (1981) Reporting results of cancer treatment. Cancer, 47: 207–214.
Morton, R. P., Rugman, F., Dorman, E. B., Stoney, P. J., Wilson, J. A., McCormick, M. A., Veevers, A., Stell, P. M. (1985) Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomized factorial phase III controlled trial. Cancer Chemotherapy and Pharmacology, 15: 283–289.
The Liverpool Head and Neck Oncology Group (1990) A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. British Journal of Cancer, 61: 311–315.